GSK Investigational Site

Caxias do Sul 95070-560

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers — Stopped early
• A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers — Stopped early